TESARO Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.


Updates from The Motley Fool

Latest updates on Tesaro from Fool.com.
Why Opko Health is Soaring Today

What: Investors in Opko Health (NYSE: OPK) are having a pleasant day as shares of the biopharm...

Opko Health's New Era Begins

Image source: Opko Health. Following massive investments over the past two years that have swelle...



Stock Performance

View Interactive TSRO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Tesaro.
Current Price: $129.97
Prev Close: $131.54
Open: $132.64
Bid: $128.60
Ask: $135.00
Day's Range: $128.68 - $134.86
52wk Range: $29.51 - $148.74
Volume: 666,399
Avg Vol 1,117,108
Market Cap: $5B
P/E (ttm): -17.92
EPS (ttm): ($7.34)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Tesaro.
CAPS Rating 2 out of 5
 
39 Outperform
14 Underperform
CAPS All Stars
 
13 Outperform
8 Underperform

How do you think Tesaro will perform against the market?



You pick for Tesaro is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Tesaro.

TESARO Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers